UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Marietta Wealth Management LLC

Marietta Wealth Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,969 shares of the healthcare conglomerate’s stock after acquiring an additional 87 shares during the period. UnitedHealth Group makes up approximately 1.4% of Marietta Wealth Management LLC’s portfolio, making the stock its 21st biggest holding. Marietta Wealth Management LLC’s holdings in UnitedHealth Group were worth $7,881,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Robbins Farley purchased a new stake in UnitedHealth Group during the third quarter worth $25,000. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at $26,000. CGC Financial Services LLC boosted its stake in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC boosted its stake in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its stake in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $25.35 during midday trading on Tuesday, reaching $470.98. 7,802,370 shares of the company traded hands, compared to its average volume of 4,349,806. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm has a market capitalization of $434.21 billion, a price-to-earnings ratio of 19.62, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The company has a fifty day moving average price of $491.15 and a 200 day moving average price of $515.88.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.37. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.7 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on UNH shares. Barclays started coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target on the stock. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. TD Cowen decreased their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Finally, HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a report on Thursday, April 4th. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $573.80.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.